Avalo Therapeutics Added to Russell 2000 and Russell 3000 Indexes
AVTX•Avalo Therapeutics will be added to the small-cap Russell 2000 and broad-market Russell 3000 Indexes after U.S. markets close on June 26, 2026. Passive and institutional managers tracking these benchmarks may increase demand for Avalo’s shares following the reconstitution.
1. Index Inclusion Details
Effective after the close of U.S. markets on June 26, 2026, Avalo Therapeutics will be added to both the Russell 2000 and Russell 3000 Indexes as part of the annual Russell reconstitution process.
2. Role of Russell Indexes
The Russell 3000 Index tracks performance of the largest 3,000 U.S. companies, representing roughly 96% of the investable equity market, while the Russell 2000 subset serves as the leading benchmark for small-cap equities.
3. Market Impact
Inclusion typically prompts passive and institutional managers to purchase shares, potentially boosting Avalo’s trading volume and liquidity and attracting investors focused on small-cap biotechnology growth names.
